CTLA4-Ig-Based Conditioning Regimen to Induce Tolerance to Cardiac Allografts

Journal of Surgical Research

Volumn 136, Issue 2, 2006, Pages 238-246

  Li, Sen ^a   Salgar, Shashikumar K ^a   Thanikachalam, Mohan ^a   Murdock, Alan D ^b   Gammie, James S ^b   Demetris, Anthony J ^b   Zeevi, Adriana ^b   Pham, Si M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

bone marrow; CTLA4 Ig; graft; heart; organ rejection; tolerance; transplantation

Indexed keywords

ABATACEPT; LYMPHOCYTE ANTIBODY; TSUKUBAENOLIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CARDIAC GRAFT REJECTION; CELL TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; HEMATOPOIETIC CELL; HISTOPATHOLOGY; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE CULTURE; MYELOABLATIVE CONDITIONING; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RAT; SKIN GRAFT; SKIN TRANSPLANTATION; T CELL DEPLETION; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNE TOLERANCE; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTES; RATS; RATS, INBRED ACI; RATS, INBRED WF; SKIN TRANSPLANTATION; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 33750956378     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.05.032     Document Type: Article

References (49)

1. Hosenpud J.D., Bennett L.E., Keck B.M., Boucek M.M., and Novick R.J. The registry of the international society for heart and lung transplantation: Eighteenth official report. J Heart Lung Transplant 20 (2001) 805
2. Owen R.D. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 102 (1945) 400
3. Brent L. The discovery of immunologic tolerance. Hum Immunol 52 (1997) 75
4. Billingham R.E., Brent L., and Medawar P.B. Actively acquired tolerance of foreign cells. Nature (London) 172 (1953) 603
5. Ildstad S.T., and Sachs D.H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307 (1984) 168
6. Starzl T.E., Demetris A.J., Murase N., Thomson A.W., Trucco M., and Ricordi C. Donor cell chimerism permitted by immunosuppressive drugs: A new view of organ transplantation. Immunol Today 14 (1993) 326
7. Starzl T.E. Chimerism and tolerance in transplantation. Proc Natl Acad Sci U S A 2 (2004) 14607
8. Salgar S.K., Shapiro R., Dodson F., et al. Infusion of donor leukocytes to induce tolerance in organ allograft recipients. J Leukoc Biol 66 (1999) 310
9. Mathew J., Fuller L., Carreno M., et al. Involvement of multiple subpopulations of human bone marrow cells in the regulation of allogeneic cellular immune responses. Transplantation 70 (2000) 1752
10. Jacquet E.G., Schanie C.L., Fugier-Vivier I., Willer S.S., and Ildstad S.T. Facilitating cells as a venue to establish mixed chimerism and tolerance. Pediatr Transplant 7 (2003) 348
11. Delis S., Ciancio G., Burke III G.W., Garcia-Morales R., and Miller J. Donor bone marrow transplantation: Chimerism and tolerance. Transpl Immunol 13 (2004) 105
12. Tinckam K.J., and Sayegh M.H. Transplantation tolerance in pediatric recipients: Lessons and challenges. Pediatr Transplant 9 (2005) 17
13. Ledbetter J.A., Imboden J.B., Schieven G.L., et al. CD28 ligation in T-cell activation: Evidence for two signal transduction pathways. Blood 75 (1990) 1531
14. Mackey M.F., Barth Jr. R.J., and Noelle R.J. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leukoc Biol 63 (1998) 418
15. Kenyon N.S., Fernandez L.A., Lehmann R., et al. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Proc Natl Acad Sci 96 (1999) 8132
16. Najafian N., and Sayegh M.H. CTLA4-Ig: A novel immunosuppressive agent. Exp Opin Invest Drugs 9 (2000) 2147
17. Anam K., Akpinar E., Craighead N., Black A., and Hale D.A. Targeted T-cell depletion or CD154 blockade generates mixed hemopoietic chimerism and donor-specific tolerance in mice treated with sirolimus and donor bone marrow. Transplantation 78 (2004) 1290
18. Linsley P., Brady W., Urnes M., Grosmaire L.S., Damle N.K., and Ledbetter J.A. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 174 (1991) 561
19. Gammie J.S., Li S., Colson Y.L., et al. A partial conditioning strategy for achieving mixed chimerism in the rat: Tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment. Exp Hematol 26 (1998) 927
20. Kunz H.W., Cortese Hassett A.L., Inomata T., Misra D.N., and Gill III T.J. The RT1. G locus in the rat encodes a Qa/TL-like antigen. Immunogenetics 30 (1989) 181
21. Vallera D.A., and Blazar B.R. T cell depletion for graft-versus-host disease prophylaxis. A perspective on engraftment in mice and humans. Transplantation 47 (1989) 751
22. Ono K., and Lindsey E.S. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 57 (1969) 225
23. Billingham R.E. Free skin grafting in mammals. In: Billingham R.E., and Silvers W.K. (Eds). Transplantation of tissues and cells (1961), The Wistar Institute Press, Philadelphia 1-26
24. Demetris A.J., Murase N., Ye Q., et al. Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol 150 (1997) 563
25. Hoffman R.A., Langrehr J.M., Billiar T.R., Curran R.D., and Simmons R.L. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol 145 (1990) 2220
26. Gammie J.S., Li S., Zeevi A., Demetris A.J., Ildstad S.T., and Pham S.M. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts. Circulation 98 (1998) II163
27. Pham S.M., Mitruka S.N., Youm W., et al. Mixed hematopoietic chimerism induces donor-specific tolerance for lung allografts in rodents. Am J Respir Crit Care Med 159 (1999) 199
28. Ildstad S.T., Wren S.M., Bluestone J.A., Barbieri S.A., and Sachs D.H. Characterization of mixed allogeneic chimeras: Immunocompetence, in vitro reactivity and genetic specificity of tolerance. J Exp Med 162 (1985) 231
29. Sharabi Y., and Sachs D.H. Mixed chimerism and permanent specific transplantation toleranceinduced by a nonlethal preparative regimen. J Exp Med 169 (1989) 493
30. Pearson T.C., Alexander D.Z., Hendrix R., et al. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism. Transplantation 61 (1996) 997
31. Wekerle T., Kurtz J., Ito H., et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 6 (2000) 464
32. Sykes M., Szot G.L., Swenson K.A., and Pearson D.A. Induction of high levels of allogeneic hematopoietic reconstitution and donor specific tolerance without myelosuppressive conditioning. Nat Med 3 (1997) 783
33. Storb R., Yu C., Zaucha J.M., et al. Stable mixed hematopoietic chimerism in dogs given donor antigen. CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant. Blood 94 (1999) 2523
34. Cobbold S., Martin G., Qin S., et al. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 323 (1986) 164
35. Colson Y.L., Zadach K., Nalesnik M., and Ildstad S.T. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts. Transplantation 60 (1995) 971
36. Flanagan W.M., Corthesy B., Bram R.J., and Crabtree G.R. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352 (1991) 803
37. Storb R., Yu C., Wagner J.L., et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89 (1997) 3048
38. Wagner J.E. Prevention of graft failure by cyclosporine in rats receiving lymphocyte-depleted MHC-mismatched bone marrow. Transplantation 53 (1992) 624
39. Linsley P.S., Clark E.A., and Ledbetter J.A. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci U S A 87 (1990) 5031
40. Linsley P.S., Greene J.L., Tan P., et al. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med 176 (1992) 1595
41. Li S., Thanikachalam M., Pang M., Carreno M., Aitouche A., and Pham S.M. Combined host-conditioning with CTLA4-Ig, tacrolimus, anti-lymphocyte serum, and low-dose radiation leads to stable mixed hematopoietic chimerism. Exp Hematol 29 (2001) 534
42. Jin Y., Zhang Q., Hao J., Gao X., Guo Y., and Xie S. Simultaneous administration of a low-dose mixture of donor bone marrow cells and splenocytes plus adenovirus containing the CTLA4Ig gene result in stable mixed chimerism and long-term survival of cardiac allograft in rats. Immunology 110 (2003) 275
43. Kirk A.D., Harlan D.M., Armstrong N.N., et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 94 (1997) 8789
44. Lin H., Bolling S.F., Linsley P.S., et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 78 (1993) 1801
45. Wekerle T., Sayegh M.H., Hill J., et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 187 (1998) 2037
46. Kaufman C.L., Colson Y.L., Wren S.M., Watkins S., Simmons R.L., and Ildstad S.T. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84 (1994) 2436
47. Hanash A.M., and Levy R.B. Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood 105 (2005) 1828
48. Hess A.D. Modulation of graft-versus-host disease: Role of regulatory T lymphocytes. Biol Blood Marrow Transplant 12 (2006) 13
49. Grimes H.L., Schanie C.L., Huang Y., et al. Graft facilitating cells are derived from hematopoietic stem cells and functionally require CD3, but are distinct from T lymphocytes. Exp Hematol 32 (2004) 946